Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 43 | $31,057,627 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
16 May 2024 08:02 | LH | LABORATORY CORP OF AMERICA HOLDINGS | VAN DER VAART SANDRA D | EVP, Chief Legal Officer | 14 May 2024 | Sale | 200 | 210.835 | 42,167 | D |
06 Feb 2024 15:47 | LH | LABORATORY CORP OF AMERICA HOLDINGS | VAN DER VAART SANDRA D | EVP, Chief Legal Officer | 05 Feb 2024 | Sale | 193 | 220.57 | 42,570 | D |
06 Feb 2023 15:56 | LH | LABORATORY CORP OF AMERICA HOLDINGS | VAN DER VAART SANDRA D | EVP, Chief Legal Officer | 03 Feb 2023 | Sale | 173 | 253.9 | 43,925 | D |
11 Mar 2024 08:56 | LH | LABORATORY CORP OF AMERICA HOLDINGS | SUMMY AMY B. | EVP, Chief Marketing Officer | 07 Mar 2024 | Sale | 227 | 218.45 | 49,588 | D |
02 May 2024 16:29 | LH | LABORATORY CORP OF AMERICA HOLDINGS | ANDERSON KERRII B | Director | 02 May 2024 | Sale | 250 | 200.0981 | 50,025 | D |
03 Jul 2023 11:52 | LH | LABORATORY CORP OF AMERICA HOLDINGS | VAN DER VAART SANDRA D | EVP, Chief Legal Officer | 29 Jun 2023 | Sale | 212 | 240 | 50,880 | D |
02 May 2024 16:29 | LH | LABORATORY CORP OF AMERICA HOLDINGS | ANDERSON KERRII B | Director | 30 Apr 2024 | Sale | 250 | 204.135 | 51,034 | D |
09 Feb 2023 09:27 | LH | LABORATORY CORP OF AMERICA HOLDINGS | VAN DER VAART SANDRA D | EVP, Chief Legal Officer | 07 Feb 2023 | Sale | 219 | 243.01 | 53,219 | D |
15 Feb 2024 08:32 | LH | LABORATORY CORP OF AMERICA HOLDINGS | VAN DER VAART SANDRA D | EVP, Chief Legal Officer | 13 Feb 2024 | Sale | 237 | 226.45 | 53,669 | D |
09 Feb 2024 12:19 | LH | LABORATORY CORP OF AMERICA HOLDINGS | VAN DER VAART SANDRA D | EVP, Chief Legal Officer | 08 Feb 2024 | Sale | 259 | 222.06 | 57,514 | D |
16 Feb 2023 12:51 | LH | LABORATORY CORP OF AMERICA HOLDINGS | SCHROEDER MARK S | EVP, President-Diagnostics Lab | 14 Feb 2023 | Sale | 309 | 247.63 | 76,518 | D |
06 Feb 2023 15:51 | LH | LABORATORY CORP OF AMERICA HOLDINGS | SCHROEDER MARK S | EVP, President-Diagnostics Lab | 03 Feb 2023 | Sale | 324 | 253.9 | 82,264 | D |
09 Aug 2024 10:16 | LH | LABCORP HOLDINGS Inc | ANDERSON KERRII B | Director | 07 Aug 2024 | Sale | 414 | 225 | 93,150 | D |
09 Feb 2023 09:04 | LH | LABORATORY CORP OF AMERICA HOLDINGS | SCHROEDER MARK S | EVP, President-Diagnostics Lab | 07 Feb 2023 | Sale | 409 | 243.01 | 99,391 | D |
22 Feb 2024 15:04 | LH | LABORATORY CORP OF AMERICA HOLDINGS | DIVINCENZO JONATHAN P. | EVP, Pres, Central Labs & Intl | 21 Feb 2024 | Sale | 500 | 215.4901 | 107,745 | D |
09 Aug 2024 10:16 | LH | LABCORP HOLDINGS Inc | ANDERSON KERRII B | Director | 08 Aug 2024 | Sale | 586 | 225 | 131,850 | D |
10 Nov 2022 08:40 | LH | LABORATORY CORP OF AMERICA HOLDINGS | SCHROEDER MARK S | EVP, President-Diagnostics Lab | 08 Nov 2022 | Sale | 1,116 | 232.67 | 259,660 | D |
20 Nov 2023 12:23 | LH | LABORATORY CORP OF AMERICA HOLDINGS | WILKINSON PETER J | SVP, Chief Accounting Officer | 16 Nov 2023 | Sale | 1,384 | 210.713 | 291,627 | D |
22 May 2023 15:08 | LH | LABORATORY CORP OF AMERICA HOLDINGS | SCHROEDER MARK S | EVP, Pres Diagnostics & COO | 18 May 2023 | Sale | 1,500 | 216.77 | 325,155 | D |
22 Feb 2024 15:05 | LH | LABORATORY CORP OF AMERICA HOLDINGS | EISENBERG GLENN A | Chief Financial Officer, EVP | 21 Feb 2024 | Sale | 1,553 | 217.9842 | 338,529 | D |
16 May 2024 08:02 | LH | LABORATORY CORP OF AMERICA HOLDINGS | VAN DER VAART SANDRA D | EVP, Chief Legal Officer | 14 May 2024 | Sale | 1,800 | 210.8268 | 379,488 | D |
21 Aug 2024 09:08 | LH | LABCORP HOLDINGS Inc | VAN DER VAART SANDRA D | EVP, Chief Legal Officer | 19 Aug 2024 | Sale | 2,000 | 227.05 | 454,100 | D |
01 May 2024 18:29 | LH | LABORATORY CORP OF AMERICA HOLDINGS | WILKINSON PETER J | SVP, Chief Accounting Officer | 29 Apr 2024 | Sale | 2,439 | 204.329 | 498,358 | D |
07 Aug 2024 08:47 | LH | LABCORP HOLDINGS Inc | BERBERIAN LANCE | EVP, CIO & CTO | 05 Aug 2024 | Sale | 2,245 | 229.785 | 515,867 | D |
28 Sep 2022 09:12 | LH | LABORATORY CORP OF AMERICA HOLDINGS | EISENBERG GLENN A | Chief Financial Officer, EVP | 26 Sep 2022 | Sale | 2,830 | 211.8634 | 599,573 | D |
19 Aug 2024 10:22 | LH | LABCORP HOLDINGS Inc | EISENBERG GLENN A | Chief Financial Officer, EVP | 15 Aug 2024 | Sale | 2,950 | 223.6169 | 659,670 | D |
19 Aug 2024 10:22 | LH | LABCORP HOLDINGS Inc | EISENBERG GLENN A | Chief Financial Officer, EVP | 15 Aug 2024 | Sale | 2,979 | 222.6494 | 663,273 | D |
03 Apr 2024 08:34 | LH | LABORATORY CORP OF AMERICA HOLDINGS | SUMMY AMY B. | EVP, Chief Marketing Officer | 01 Apr 2024 | Sale | 3,500 | 217.29 | 760,515 | D |
29 Mar 2024 17:54 | LH | LABORATORY CORP OF AMERICA HOLDINGS | VAN DER VAART SANDRA D | EVP, Chief Legal Officer | 28 Mar 2024 | Sale | 3,553 | 216.74 | 770,077 | D |
03 Apr 2023 10:05 | LH | LABORATORY CORP OF AMERICA HOLDINGS | SCHROEDER MARK S | EVP, President-Diagnostics Lab | 31 Mar 2023 | Sale | 3,897 | 225.81 | 879,982 | D |
23 May 2023 08:06 | LH | LABORATORY CORP OF AMERICA HOLDINGS | KIRCHGRABER PAUL R | CEO, Covance Drug Development | 19 May 2023 | Sale | 4,300 | 216.9086 | 932,707 | D |
28 Sep 2022 09:12 | LH | LABORATORY CORP OF AMERICA HOLDINGS | EISENBERG GLENN A | Chief Financial Officer, EVP | 26 Sep 2022 | Sale | 4,844 | 210.2068 | 1,018,242 | D |
10 Aug 2023 08:55 | LH | LABORATORY CORP OF AMERICA HOLDINGS | ANDERSON KERRII B | Director | 08 Aug 2023 | Sale | 5,000 | 211.5665 | 1,057,832 | D |
11 Mar 2024 08:59 | LH | LABORATORY CORP OF AMERICA HOLDINGS | SCHROEDER MARK S | EVP, Pres Diagnostics & COO | 07 Mar 2024 | Sale | 5,048 | 218.45 | 1,102,736 | D |
28 Sep 2022 09:12 | LH | LABORATORY CORP OF AMERICA HOLDINGS | EISENBERG GLENN A | Chief Financial Officer, EVP | 26 Sep 2022 | Sale | 5,627 | 209.294 | 1,177,697 | D |
03 Apr 2024 08:35 | LH | LABORATORY CORP OF AMERICA HOLDINGS | SCHROEDER MARK S | EVP, Pres Diagnostics & COO | 01 Apr 2024 | Sale | 6,477 | 217.29 | 1,407,387 | D |
22 Feb 2024 15:05 | LH | LABORATORY CORP OF AMERICA HOLDINGS | EISENBERG GLENN A | Chief Financial Officer, EVP | 21 Feb 2024 | Sale | 6,665 | 217.5205 | 1,449,774 | D |
22 Feb 2024 15:05 | LH | LABORATORY CORP OF AMERICA HOLDINGS | EISENBERG GLENN A | Chief Financial Officer, EVP | 21 Feb 2024 | Sale | 7,907 | 215.6759 | 1,705,349 | D |
23 Feb 2023 09:54 | LH | LABORATORY CORP OF AMERICA HOLDINGS | KIRCHGRABER PAUL R | CEO, Covance Drug Development | 21 Feb 2023 | Sale | 8,000 | 250.5844 | 2,004,675 | D |
19 Aug 2024 10:22 | LH | LABCORP HOLDINGS Inc | EISENBERG GLENN A | Chief Financial Officer, EVP | 15 Aug 2024 | Sale | 9,071 | 224.5488 | 2,036,882 | D |
07 Aug 2024 08:47 | LH | LABCORP HOLDINGS Inc | BERBERIAN LANCE | EVP, CIO & CTO | 05 Aug 2024 | Sale | 9,848 | 228.9485 | 2,254,685 | D |
28 Sep 2022 09:12 | LH | LABORATORY CORP OF AMERICA HOLDINGS | EISENBERG GLENN A | Chief Financial Officer, EVP | 26 Sep 2022 | Sale | 11,699 | 211.1346 | 2,470,064 | D |
22 Feb 2024 15:05 | LH | LABORATORY CORP OF AMERICA HOLDINGS | EISENBERG GLENN A | Chief Financial Officer, EVP | 21 Feb 2024 | Sale | 18,379 | 215.3661 | 3,958,214 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)